Latest Shareholder Dilution News

Page 1 of 26
Adherium has tapped its major shareholder, Trudell Medical, for a further AUD 1 million unsecured loan to bolster working capital, adding to a recent USD 1.65 million facility.
Ada Torres
Ada Torres
18 Aug 2026
RLF AgTech is set to raise $3.9 million through a share placement and convertible notes, aiming to capitalise on recent operational restructuring and accelerate commercial execution in FY27.
Ada Torres
Ada Torres
12 Aug 2026
PM Capital Global Opportunities Fund (ASX: PGF) is raising up to $195 million through a $175 million placement and a $20 million share purchase plan at $3.07 per share, matching its net tangible asset value and offering a fully franked 7.5 cent dividend for 2026.
Claire Turing
Claire Turing
11 Aug 2026
Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.
Ada Torres
Ada Torres
10 Aug 2026
WAM Income Maximiser (ASX: WMX) has kicked off a $125.4 million entitlement offer priced at $1.62 per share, alongside a $47 million placement, aiming to bolster its capital base while maintaining a 7.1% fully franked dividend yield.
Claire Turing
Claire Turing
5 Aug 2026
Anson Resources has secured a conditional US$357.7 million incentive package proposal from Utah authorities, potentially easing capital and tax burdens for its Green River Lithium Project and enhancing its financial outlook.
Maxwell Dee
Maxwell Dee
5 Aug 2026
Mayfield Childcare has launched a $3 million entitlement offer, fully covered by major shareholder pre-commitments and partial underwriting, to bolster working capital and support its operational turnaround amid ongoing sector challenges.
Victor Sage
Victor Sage
3 Aug 2026
Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.
Ada Torres
Ada Torres
30 July 2026
Everest Metals is set to begin toll processing at its Mt Dimer Gold Project in September 2026, backed by strong mining progress and promising high-grade drill results.
Maxwell Dee
Maxwell Dee
30 July 2026
Thor Energy reported a robust cash position of A$2.8 million at June 30, 2026, and confirmed natural hydrogen concentrations up to 3% at its HY-Range Project. The company awarded a fully funded 464 line-kilometre 2D seismic survey to Velseis, marking a key step towards drilling.
Maxwell Dee
Maxwell Dee
29 July 2026
Cavalier Resources has lifted the net present value of its Crawford Gold Project by 50%, securing a $23 million financing package and advancing pre-production activities as it moves closer to development.
Maxwell Dee
Maxwell Dee
29 July 2026
The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.
Victor Sage
Victor Sage
27 July 2026

Browse the archive

Full archive